Richard Matt, Principal Consultant at Aspen Medical Risk Consulting, leads a breakout session on achieving post-market excellence through evolved vigilance practices. As regulatory expectations for post-market surveillance continue to intensify, safety organizations must transform their approaches to adverse event detection, signal management, and benefit-risk assessment.
Richard will present a maturity model for post-market vigilance that helps organizations benchmark their current capabilities and identify priority areas for improvement. The session will cover advanced signal detection methodologies, the integration of real-world data sources into safety monitoring, and strategies for building a continuous improvement culture within safety teams.
This session is designed for safety and quality professionals who want to move beyond minimum compliance and build post-market capabilities that create genuine competitive advantage.
Minutes will be published after the session.
This section will be populated during/after the session.
This section will be populated during/after the session.
This section will be populated during/after the session.
This section will be populated during/after the session.
Reflect on how this session's insights apply to your role. Sign in to add personal notes.
How does this session connect to your responsibilities? Sign in to capture personal relevance notes.
Track
Drug safety, pharmacovigilance, regulatory compliance
Aparna Ahuja
Mike Xie, Subhadip Jana
Leo Park
Edward Chekan, Humberto Valbuena